We Think in Real Time.
AiM Medical Robotics is a neurosurgical robotics company that is working to bring high levels of precision, automation, and efficiency, to the complex environment of neurosurgery. We are developing a portable MRI compatible surgical robot for use in the MRI Suite and the Operating Room. Our mission is to improve outcomes for patients undergoing neurosurgery for Functional brain disorders (Parkinson’s, Epilepsy, etc) and cancer, while providing cost savings to hospitals by eliminating errors and reducing procedure time by up to 50%.
Team
Leadership Team

Gregory Fischer, PhD
CEO/President, Founder & Co-inventor

Julie G. Pilitsis, MD, PhD, MBA
Chair of Medical Advisory Board, Founder, and Co-Inventor

John Gomes
Chief Commercial Officer & Board Member

Joe Heanue, PhD
Board Member, President and CEO of Triple Ring Technologies

Rachel LeBlanc
Chief Operations Officer & Board Secretary

Jonathan Sackier, MB, ChB, FRCS, FACS, DSC
Chief Medical Officer, Board Member
Medical Advisory Board

Sharona Ben-Haim, MD
Surgical Director of Epilepsy, Associate Professor of Neurological Surgery

David Charles, MD
Professor and Vice-Chair of Neurology

Paul S. Larson, MD, FAANS
Professor of Neurosurgery at the University of Arizona
Chief of Neurosurgery at the Southern Arizona VA Health Care System<

John Rolston, MD, PhD
Director of Epilepsy Surgery
Director of the Mapping & Engineering Neural Dynamics (MEND) Laboratory
Associate Professor, Harvard Medical School

Joshua M Rosenow, MD, FAANS, FCNS, FACS
Director of Functional Neurosurgery, Northwestern University Memorial Hospital

Jon T. Willie, MD, PhD
Director of Stereotactic and Epilepsy Surgery, Department of Neurosurgery, Washington University, St. Louis
Business Advisors

Yulun Wang, PhD
Corporate Advisor, Founder and Chairman Computer Motion. Founder and Chairman InTouch Health

Samantha Surrey
Business Advisor, Founder of Surrey Capital Partners

Scott Davis, PhD
Board Observer, Senior Associate, Life Sciences at Sontag Innovation Fund

David Noonan, PhD
Corporate Advisor, Chief Technology Officer at Moon Surgical, Senior Director R+D at Auris Health

Alex Wilson
Board Observer, Principal at IQ Capital

Andrea Bajo, PhD
Engineering and Development Advisor

Sabrina Varanelli
Quality Systems Advisor

Dave Saunders
Product Development Advisor

Terry Lopaka Adams
Board Observer, Director of Technology Commercialization at WPI

Tom Hirschfeld
Board Observer, Board Member, HBS Alumni Angels of NY.
News
AiM Medical Robotics Secures $8.1 Million Series A Financing to Transform Neurosurgery with MRI-Compatible Surgical Robotics
Sep 30, 2025 | READ MOREAiM Medical Robotics Announces Co-Founder Dr. Julie Pilitsis Elected as President of the American Society for Stereotactic and Functional Neurosurgery
Aug 21, 2024 | READ MOREAiM Medical Robotics Partners with Brigham and Women’s Hospital for a First Human Clinical Study for MRI-guided Device Placement in the Brain
May 21, 2024 | READ MOREAiM Medical Robotics Announces Changes to Executive Team and Participation in LSI Emerging Medtech Summit
Mar 08, 2023 | READ MOREAiM Medical Robotics Unveils Prototype of MRI-Compatible Intraoperative Robot for Neurosurgery and Receives Funding from Sontag Foundation Innovation Fund
Aug 22, 2022 | READ MOREAiM Medical Robotics Raises $3.4M in Seed Financing to Advance Neurosurgery with MRI-Compatible Robotics
Mar 15, 2022 | READ MOREAiM Medical Robotics Appoints Dr. Jonathan M. Sackier as Chief Medical Officer
Mar 03, 2022 | READ MOREAiM Medical Robotics Appoints Dr. Gregory Cole as Chief Technology Officer
Feb 17, 2022 | READ MOREAiM Medical Robotics to Host Panel Discussion and Present at Biofuture™
Sep 30, 2021 | READ MOREAiM Medical Robotics Appoints Dr. Babak Kateb to Medical Advisory Board
Jul 29, 2021 | READ MOREAiM Medical Robotics to Present and Exhibit at 18th Annual World Congress of Society for Brain Mapping and Therapeutics (SBMT)
Jul 07, 2021 | READ MOREAiM Medical Robotics Appoints Jonathan Sackier to the Board of Directors
May 11, 2021 | READ MOREMedia
See more content on our YouTube Channel

Gregory Fischer, AiM Medical Robotics – Portable MRI Compatible Surgical Robot
Presented at LSI USA '24

How AiM Medical Robotics is Changing Neurosurgery with Founder Gregory Fischer, PhD
State of MedTech Podcast

Beyond General Surgery: The Next Frontiers in Medical Robotics
Presented at LSI USA ‘23
Contact
If you would like to contact us, please complete the form below.
We will reply as soon as possible.

AiM Medical Robotics
Practice Point
50 Prescott St.
Worcester, MA 01605
Tel: (617)-203-5560
Investors
AiM Medical Robotics is an early stage growth company supported by a number of funds including IQ Capital and Surrey Capital Partners. For more information, please email us at ir@aimmedrobotics.com.
This device is investigational and not approved by the FDA
Forward-Looking Statement
This website includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. These statements are based on AiM’s current expectations, estimates, and projections about our industry, our business, and the device we are developing; and are subject to substantial risks, uncertainties and assumptions. The statements concern AiM’s business strategies; research and development plans; the timing of regulatory submissions; the ability to obtain and maintain regulatory authorizations of AiM’s products; market acceptance of AiM’s products; AiM’s intellectual property; AiM’s reliance on third party organizations; AiM’s competitive position; AiM’s industry environment; AiM’s anticipated financial and operating results, including anticipated sources of revenues; AiM’s assumptions regarding the size of the available market, the benefits of AiM’s products; product pricing and timing of product launches; management’s expectation with respect to future acquisitions; AiM’s goals, intentions, plans and expectations, including the introduction of new products and markets; and AiM’s cash needs and financing plans. Actual events may differ materially from the expectations indicated by such forward-looking statements. You should not place undue reliance on these forward-looking statements, which can be identified by words such as “could,” “believe,” “anticipate,” “intend,” “believe,” “estimate,” “expect,” “may,” “will,” “could,” “continue,” “predict,” “potential,” “project” or similar terms, variations of such terms or the negative of those terms. Our medical device is currently in development and remains subject to significant risks and uncertainties, including, but not limited to, delays or difficulties in preclinical and clinical testing, obtaining required regulatory authorizations, supply chain and/or manufacturing challenges, changes in market conditions, and potential competition. The timing and outcome of regulatory reviews and clinical trial results are inherently uncertain and could adversely affect the commercial viability of our product. AiM may not realize its expectations or achieve its plans. Actual results may differ materially from those indicated by these forward-looking statements as a result of various factors, including those described in our filings with the Securities and Exchange Commission (SEC), such as risk factors contained in our most recent Annual Report on Form 10-K. All forward-looking statements reflect current beliefs and assumptions of AiM management as of the date of this [document/press release]. Consequently, forward-looking statements should be regarded solely as AiM’s current plans, estimates, and beliefs. AiM cannot guarantee future results, events, or performance. AiM does not undertake and specifically declines any obligation to update or revise any forward-looking statements to reflect new information, future events or circumstances or to reflect the occurrences of unanticipated events, except as may be required by applicable law.